About this trial
Transcranial magnetic stimulation (TMS) is increasingly being applied to effectively treat mental illness, however efforts to quantify the effects of TMS on the network architecture of the brain have largely been limited in scope and tied to specific neurologic and psychiatric disorders. The objective of the current work is to build and validate a whole-brain, domain-general model of brain connectivity changes following TMS, based on physical models of the current distribution at the cortex. PUBLIC HEALTH RELEVANCE: This work is relevant to public health because it will provide direct evidence that brain connectivity changes following neuromodulatory TMS vary as a function of the current density at the cortex, which can be used to predict psychiatric symptom change following neuromodulatory TMS.
Eligibility criteria
Qualifiers
Able to give their consent
Right-handed
Disqualifiers
Non-english speaking
Any significant medical problems
Current or past Axis I psychiatric disorder(s),
Active or history of active suicidal ideation
Trial design
Treatments tested in this trial
- Intermittent Theta Burst Stimulation
- Continuous Theta Burst Stimulation
Treatment groups
Sponsors and collaborators
Nicholas Balderston, PhD
Lead sponsor
University of Pennsylvania
Sponsor institution